Screener
Aclaris Therapeutics ACRS Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $1.63M-8.3% | $2M+37.2% | $1.3M-85.9% | $3.3M-24.1% | $1.78M-35.8% | ||
| $218K-57.7% | $395K-21.9% | $532K-24.5% | $538K-17.7% | $515K-17.5% | ||
| $18.07M+57.8% | $15.66M+35.2% | $16.58M+83.7% | $13.03M+119% | $11.45M+30.7% | ||
| $6.05M+12.3% | $6.74M+9.8% | $5.58M+12.6% | $4.87M-13.8% | $5.39M+13.3% | ||
| $25.87M+28.1% | $24.19M+23.8% | $24.03M-77.9% | $20.45M+38.0% | $20.19M+29.2% | ||
| -$24.24M-31.7% | -$22.19M-22.7% | -$22.73M+77.2% | -$17.15M-63.8% | -$18.41M-43.2% | ||
| -1,487.9%-452pp | -1,111.8%+131pp | -1,755.5%-673pp | -519.8%-279pp | -1,035.9%-571pp | ||
| $2.73M-8.3% | $2.37M-21.0% | $2.94M-5.9% | $2.54M-12.1% | $2.98M+59.5% | ||
| -$21.51M-39.4% | -$19.82M-31.4% | -$19.8M+79.5% | -$14.61M-92.6% | -$15.43M-40.4% | ||
| -1,320.1%-452pp | -993.2%+43.6pp | -1,528.6%-480pp | -443%-268pp | -868.3%-471pp | ||
| -$0.15-15.4% | -$0.15-25.0% | -$0.16+86.8% | -$0.12-9.1% | -$0.13+13.3% | ||
| -$24.13M-31.9% | -$22.09M-23.0% | -$22.63M+77.3% | -$17.04M-65.6% | -$18.29M-45.1% | ||
| -1,481.3%-452pp | -1,106.7%+127pp | -1,747.6%-667pp | -516.5%-280pp | -1,029.5%-574pp | ||
| -$24.24M-31.7% | -$22.19M-22.7% | -$22.73M+77.2% | -$17.15M-63.8% | -$18.41M-43.2% |
FAQ
- What is Aclaris Therapeutics's revenue?
- Aclaris Therapeutics (ACRS) generated $8.2M in revenue over the trailing twelve months, down 51.0% year over year.
- Is Aclaris Therapeutics profitable?
- Aclaris Therapeutics is not currently profitable: it reported a net loss of $75.7M over the trailing twelve months, a -921.5% net margin.
- What are Aclaris Therapeutics's profit margins?
- Gross margin is 79.5% and operating margin is -1050.2%, with a -921.5% net margin.
- What is Aclaris Therapeutics's earnings per share?
- Aclaris Therapeutics's diluted EPS over the trailing twelve months is $-0.58.
- Where does Aclaris Therapeutics's income statement data come from?
- Every line is extracted from Aclaris Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
